Avenue Therapeutics Inc Sustainability Reports
Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system and neurologic diseases. The company's clinical pipeline includes development-stage product candidates such as AJ201 for spinal and bulbar muscular atrophy, BAER-101 for CNS diseases, and intravenous tramadol for postoperative pain management.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300IN52C2XAYTBO53
FIGI: BBG00GLTS5K3
1 reports from 2018 to 2018
